Titlebook: Non-Disseminated Breast Cancer; Controversial Issues Gilbert H. Fletcher (Professor),Seymour H. Levitt Book 1993 Springer-Verlag Berlin He

jungle

語源學(xué)

insidious

Book 1993o in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-st

賭博

What Is the Value of Clinical Trials?,es are proposed or introduced that challenge these existing views. Yet challenging established views, many of which are vigorously defended with only non-randomized experience, is critical to improving treatment results for early breast cancer.

窒息

How Much of the Axilla Should Be Dissected?,prevent complications arising from uncontrolled tumor growth in the axilla. Information on axillary Staging is vital when the axillary node status is a major determinant of the use of systemic therapy.

上腭

歪曲道理

Postoperative Radiotherapy and the Pattern of Distant Spread in Breast Cancer,S. 1987). However, the impact of this treatment on long-term survival remains controversial and there is a large discrepancy between the highly eflective local treatment and the somewhat modest gain in total survival (T. et al. 1986).

Vulvodynia

PAD416

跟隨

Treatment of the Peripheral Lymphatics: Rationale, Indications, and Techniques,but the efficacy of such radiation in patients with limited stage breast cancer continues to remain controversial despite decades of study. Results of clinical trials and sequelae of regional lymphatic radiation vary because of patient selection factors, treatment practice patterns, and design flaws in some clinical trials.